P. Libby, P. Ridker, and G. Hansson, Progress and challenges in translating the biology of atherosclerosis, Nature, vol.5, issue.7347, pp.317-342, 2011.
DOI : 10.1038/nature10146

M. Bennett, S. Sinha, and G. Owens, Vascular Smooth Muscle Cells in Atherosclerosis, Circulation Research, vol.118, issue.4, pp.692-702, 2016.
DOI : 10.1161/CIRCRESAHA.115.306361

R. Ross, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature, vol.362, issue.6423, pp.801-810, 1993.
DOI : 10.1038/362801a0

K. Bornfeldt, E. Raines, T. Nakano, L. Graves, E. Krebs et al., Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation., Journal of Clinical Investigation, vol.93, issue.3, pp.1266-74, 1994.
DOI : 10.1172/JCI117081

A. Bayes?genis, C. Conover, and R. Schwartz, The Insulin-Like Growth Factor Axis : A Review of Atherosclerosis and Restenosis, Circulation Research, vol.86, issue.2, pp.125-155, 2000.
DOI : 10.1161/01.RES.86.2.125

Y. Ebina, M. Edery, L. Ellis, D. Standring, J. Beaudoin et al., Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells., Proceedings of the National Academy of Sciences, vol.82, issue.23, pp.8014-8022, 1985.
DOI : 10.1073/pnas.82.23.8014

A. Ullrich, A. Gray, A. Tam, T. Yang?feng, M. Tsubokawa et al., Insulin?like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity, EMBO J, vol.5, pp.2503-2515, 1986.

R. Malaguarnera and A. Belfiore, The Insulin Receptor: A New Target for Cancer Therapy, Frontiers in Endocrinology, vol.2, p.93, 2011.
DOI : 10.3389/fendo.2011.00093

C. Moxham, V. Duronio, and S. Jacobs, Insulin?like growth factor I receptor ??subunit heterogeneity. Evidence for hybrid tetramers composed of insulin?like growth factor I and insulin receptor heterodimers, J Biol Chem, vol.264, pp.13238-13282, 1989.

M. Soos, J. Whittaker, R. Lammers, A. Ullrich, and K. Siddle, Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells, Biochemical Journal, vol.270, issue.2, pp.383-90, 1990.
DOI : 10.1042/bj2700383

A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri, Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease, Endocrine Reviews, vol.30, issue.6, pp.586-623, 2009.
DOI : 10.1210/er.2008-0047

S. Seino and G. Bell, Alternative splicing of human insulin receptor messenger RNA, Biochemical and Biophysical Research Communications, vol.159, issue.1, pp.312-318, 1989.
DOI : 10.1016/0006-291X(89)92439-X

F. Frasca, G. Pandini, P. Scalia, L. Sciacca, R. Mineo et al., Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells, Molecular and Cellular Biology, vol.19, issue.5, pp.3278-88, 1999.
DOI : 10.1128/MCB.19.5.3278

B. Vogt, J. Carrascosa, B. Ermel, A. Ullrich, and H. Häring, The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics, Biochemical and Biophysical Research Communications, vol.177, issue.3, pp.1013-1021, 1991.
DOI : 10.1016/0006-291X(91)90639-O

L. Sciacca, M. Prisco, A. Wu, A. Belfiore, R. Vigneri et al., Signaling Differences from the A and B Isoforms of the Insulin Receptor (IR) in 32D Cells in the Presence or Absence of IR Substrate-1, Endocrinology, vol.144, issue.6, pp.2650-2658, 2003.
DOI : 10.1210/en.2002-0136

O. Escribano, A. Gómez?hernández, S. Díaz?castroverde, C. Nevado, G. García et al., Insulin receptor isoform A confers a higher proliferative capability to pancreatic beta cells enabling glucose availability and IGF-I signaling, Molecular and Cellular Endocrinology, vol.409, pp.82-91, 2015.
DOI : 10.1016/j.mce.2015.03.008

O. Escribano, C. Guillén, C. Nevado, A. Gómez?hernández, C. Kahn et al., Beta?cell hyperplasia induced by hepatic insulin resistance: role of a liver?pancreas endocrine axis through insulin receptor A isoform, Diabe? tes, vol.58, pp.820-828, 2009.

S. Diaz?castroverde, A. Gómez?hernández, S. Fernández, G. García?gómez, D. Scala et al., Insulin receptor isoform A ameliorates long-term glucose intolerance in diabetic mice, Disease Models & Mechanisms, vol.9, issue.11, pp.1271-81, 2016.
DOI : 10.1242/dmm.025288

S. Diaz?castroverde, S. Baos, M. Luque, D. Scala, M. González?aseguinolaza et al., Prevalent role of the insulin receptor isoform A in the regulation of hepatic glycogen metabolism in hepatocytes and in mice, Diabetologia, vol.58, issue.12, pp.2702-2712, 2016.
DOI : 10.1007/s00125-016-4088-z

L. Sciacca, A. Costantino, G. Pandini, R. Mineo, F. Frasca et al., Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism, Oncogene, vol.18, issue.15, pp.2471-2480, 1999.
DOI : 10.1038/sj.onc.1202600

A. Gómez?hernández, Ó. Escribano, L. Perdomo, Y. Otero, G. García?gómez et al., Implication of Insulin Receptor A Isoform and IRA/IGF-IR Hybrid Receptors in the Aortic Vascular Smooth Muscle Cell Proliferation: Role of TNF-?? and IGF-II, Endocrinology, vol.154, issue.7, pp.2352-64, 2013.
DOI : 10.1210/en.2012-2161

M. Kuzuya, S. Kanda, T. Sasaki, N. Tamaya?mori, X. Cheng et al., Deficiency of Gelatinase A Suppresses Smooth Muscle Cell Invasion and Development of Experimental Intimal Hyperplasia, Circulation, vol.108, issue.11, pp.1375-81, 2003.
DOI : 10.1161/01.CIR.0000086463.15540.3C

A. Cho and M. Reidy, Matrix Metalloproteinase-9 Is Necessary for the Regulation of Smooth Muscle Cell Replication and Migration After Arterial Injury, Circulation Research, vol.91, issue.9, pp.845-51, 2002.
DOI : 10.1161/01.RES.0000040420.17366.2E

C. Johnson and Z. Galis, Matrix Metalloproteinase-2 and -9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.1, pp.54-60, 2004.
DOI : 10.1161/01.ATV.0000100402.69997.C3

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=

Y. Nakashima, A. Plump, E. Raines, J. Breslow, and R. Ross, ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.14, issue.1, pp.133-173, 1994.
DOI : 10.1161/01.ATV.14.1.133

J. Johnson, Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis, Cardiovascular Research, vol.103, issue.4, pp.452-60, 2014.
DOI : 10.1093/cvr/cvu171

K. Siddle, Signalling by insulin and IGF receptors: supporting acts and new players, Journal of Molecular Endocrinology, vol.47, issue.1, pp.1-10, 2011.
DOI : 10.1530/JME-11-0022

A. Bartolomé, C. Guillén, and M. Benito, Role of the TSC1-TSC2 Complex in the Integration of Insulin and Glucose Signaling Involved in Pancreatic ??-Cell Proliferation, Endocrinology, vol.151, issue.7, pp.3084-94, 2010.
DOI : 10.1210/en.2010-0048

A. Sacco, A. Morcavallo, G. Pandini, R. Vigneri, and A. Belfiore, Differential Signaling Activation by Insulin and Insulin-Like Growth Factors I and II upon Binding to Insulin Receptor Isoform A, Endocrinology, vol.150, issue.8, pp.3594-602, 2009.
DOI : 10.1210/en.2009-0377

R. Stout, Insulin as a mitogenic factor: Role in the pathogenesis of cardiovascular disease, The American Journal of Medicine, vol.90, issue.2, pp.62-67, 1991.
DOI : 10.1016/0002-9343(91)90041-U

J. Nigro, N. Osman, A. Dart, and P. Little, Insulin Resistance and Atherosclerosis, Endocrine Reviews, vol.27, issue.3, pp.242-59, 2006.
DOI : 10.1210/er.2005-0007

P. Faries, D. Rohan, H. Takahara, M. Wyers, M. Contreras et al., Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration, Journal of Vascular Surgery, vol.33, issue.3, pp.601-608, 2001.
DOI : 10.1067/mva.2001.111806

M. Yang and A. Kahn, Insulin-inhibited and stimulated cultured vascular smooth muscle cell migration are related to divergent effects on protein phosphatase-2A and autonomous calcium/calmodulin-dependent protein kinase II, Atherosclerosis, vol.196, issue.1, pp.227-260, 2008.
DOI : 10.1016/j.atherosclerosis.2007.04.050

C. Wang, I. Gurevich, and B. Draznin, Insulin Affects Vascular Smooth Muscle Cell Phenotype and Migration Via Distinct Signaling Pathways, Diabetes, vol.52, issue.10, pp.2562-2571, 2003.
DOI : 10.2337/diabetes.52.10.2562

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=

S. Abhijit, R. Bhaskaran, A. Narayanasamy, A. Chakroborty, N. Manickam et al., Hyperinsulinemia-induced vascular smooth muscle cell (VSMC) migration and proliferation is mediated by converging mechanisms of mitochondrial dysfunction and oxidative stress, Molecular and Cellular Biochemistry, vol.29, issue.580, pp.95-105, 2013.
DOI : 10.1007/s11010-012-1478-5

C. Yu, Z. Wang, Y. Han, Y. Liu, W. Wang et al., Dopamine D4 receptors inhibit proliferation and migration of vascular smooth muscle cells induced by insulin via down-regulation of insulin receptor expression, Cardiovascular Diabetology, vol.13, issue.1, pp.97-111, 2014.
DOI : 10.1186/1475-2840-13-97

. Beneit, 15:161 ? We accept pre-submission inquiries ? Our selector tool helps you to find the most relevant journal ? We provide round the clock customer support ? Convenient online submission ? Thorough peer review ? Inclusion in PubMed and all major indexing services ? Maximum visibility for your research Submit your manuscript at www.biomedcentral, com/submit Submit your next manuscript to BioMed Central and we will help you at every step, 2016.

A. Gockerman, T. Prevette, J. Jones, and D. Clemmons, Insulin?like growth factor (IGF)?binding proteins inhibit the smooth muscle cell migration responses to IGF?I and IGF?II, Endocrinology, vol.136, pp.4168-73, 1995.

C. Duan, J. Bauchat, and T. Hsieh, Phosphatidylinositol 3-Kinase Is Required for Insulin-Like Growth Factor-I-Induced Vascular Smooth Muscle Cell Proliferation and Migration, Circulation Research, vol.86, issue.1, pp.15-23, 2000.
DOI : 10.1161/01.RES.86.1.15

A. Girnita, L. Girnita, F. Del-prete, A. Bartolazzi, O. Larsson et al., Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell Growth, Cancer Research, vol.64, issue.1, pp.236-278, 2004.
DOI : 10.1158/0008-5472.CAN-03-2522

D. Vasilcanu, A. Girnita, L. Girnita, R. Vasilcanu, M. Axelson et al., The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway, Oncogene, vol.23, issue.47, pp.7854-62, 2004.
DOI : 10.1038/sj.onc.1208065

A. Frattali and J. Pessin, Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin?like growth factor?1 hybrid receptors, J Biol Chem, vol.268, pp.7393-400, 1993.

S. Chisalita and H. Arnqvist, Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells, Diabetologia, vol.89, issue.Suppl 2, pp.2155-61, 2005.
DOI : 10.1007/s00125-005-1890-4

G. Johansson and H. Arnqvist, Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells, AJP: Endocrinology and Metabolism, vol.291, issue.5, pp.1124-1154, 2006.
DOI : 10.1152/ajpendo.00565.2005

G. Pandini, F. Frasca, R. Mineo, L. Sciacca, R. Vigneri et al., Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved, Journal of Biological Chemistry, vol.277, issue.42, pp.39684-95, 2002.
DOI : 10.1074/jbc.M202766200

H. Stary, A. Chandler, R. Dinsmore, V. Fuster, S. Glagov et al., A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation, vol.92, issue.5, pp.1355-74, 1995.
DOI : 10.1161/01.CIR.92.5.1355

J. Polanco, M. Albajar, M. Pocoví, R. Rey, and J. , Induction of Insulin-like Growth Factor Receptor (IGF IR) mRNA Levels by Low Density Lipoproteins, Biochemical and Biophysical Research Communications, vol.226, issue.3, pp.917-939, 1996.
DOI : 10.1006/bbrc.1996.1450

G. Jia, G. Cheng, K. Soundararajan, and D. Agrawal, Insulin-like growth factor-I receptors in atherosclerotic plaques of symptomatic and asymptomatic patients with carotid stenosis: effect of IL-12 and IFN-??, AJP: Heart and Circulatory Physiology, vol.292, issue.2, pp.1051-1058, 2007.
DOI : 10.1152/ajpheart.00801.2006

J. Von-der-thüsen, K. Borensztajn, S. Moimas, S. Van-heiningen, P. Teeling et al., IGF-1 Has Plaque-Stabilizing Effects in Atherosclerosis by Altering Vascular Smooth Muscle Cell Phenotype, The American Journal of Pathology, vol.178, issue.2, pp.924-958, 2011.
DOI : 10.1016/j.ajpath.2010.10.007

Y. Okura, M. Brink, A. Zahid, A. Anwar, and P. Delafontaine, Decreased Expression of Insulin-like Growth Factor-1 and Apoptosis of Vascular Smooth Muscle Cells in Human Atherosclerotic Plaque, Journal of Molecular and Cellular Cardiology, vol.33, issue.10, pp.1777-89, 2001.
DOI : 10.1006/jmcc.2001.1441

Y. Higashi, S. Sukhanov, S. Shai, S. Danchuk, R. Tang et al., Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E???Deficient MiceCLINICAL PERSPECTIVE, Circulation, vol.133, issue.23, pp.2263-78, 2016.
DOI : 10.1161/CIRCULATIONAHA.116.021805

S. Zaina, L. Pettersson, B. Ahrén, L. Brånén, A. Hassan et al., Insulin-like Growth Factor II Plays a Central Role in Atherosclerosis in a Mouse Model, Journal of Biological Chemistry, vol.277, issue.6, pp.4505-4516, 2002.
DOI : 10.1074/jbc.M108061200